Von dem Buch New Drugs and Targets for Asthma and COPD haben wir 2 gleiche oder sehr ähnliche Ausgaben identifiziert!
Falls Sie nur an einem bestimmten Exempar interessiert sind, können Sie aus der folgenden Liste jenes wählen, an dem Sie interessiert sind:
100%: T.T. Hansel: New Drugs and Targets for Asthma and COPD (ISBN: 9783805595674) 2010, Erstausgabe, in Englisch, auch als eBook.Nur diese Ausgabe anzeigen…
60%: Ed. By Trevor T. Hansel, Peter J. Barnes And Bolliger; Hansel, Trevor T.; Barnes, Peter J.: New Drugs Targets for Asthma COPD (Progress in Respiratory Research) (ISBN: 9783805595667) 2010, S Karger Pub, Erstausgabe, in Deutsch, Band: 39, Broschiert.
Nur diese Ausgabe anzeigen…
Nur diese Ausgabe anzeigen…
New Drugs and Targets for Asthma and COPD - 10 Angebote vergleichen
| Preise | 2013 | 2018 | 2019 |
|---|---|---|---|
| Schnitt | € 0,00 | € 0,00 | € 364,88 |
| Nachfrage |
1
New Drugs and Targets for Asthma and COPD (Progress in Respiratory Research) (2010)
EN NW FE EB DLISBN: 9783805595674 bzw. 3805595670, in Englisch, 310 Seiten, S. Karger, neu, Erstausgabe, E-Book, elektronischer Download.
Lieferung aus: Vereinigte Staaten von Amerika, E-Book zum Download.
Asthma, allergy and chronic obstructive lung disease are common throughout the world and are increasing in incidence, particularly in the developing world. This volume provides a state-of-the-art account of the identification of new targets and the development of new therapies for these conditions. Some 40 chapters by clinical academics and senior members of the pharmaceutical industry detail the latest breakthroughs in research and development. In asthma, a promising approach is the use of therapy directed against specific Th2 responses through biological antagonists of IL-5, IL-4 and IL-13. There have also been major advances in our understanding of innate immune responses to pathogen-associated molecular patterns, and in the area of Toll-like receptors. Up to date and comprehensive, this book will be of particular relevance to those working in the pharmaceutical industry (in preclinical research and clinical development), to academic researchers in the field of respiratory medicine, and to respiratory health care specialists. Kindle Edition, Ausgabe: 1, Format: Kindle eBook, Label: S. Karger, S. Karger, Produktgruppe: eBooks, Publiziert: 2010-08-31, Freigegeben: 2010-08-31, Studio: S. Karger.
Asthma, allergy and chronic obstructive lung disease are common throughout the world and are increasing in incidence, particularly in the developing world. This volume provides a state-of-the-art account of the identification of new targets and the development of new therapies for these conditions. Some 40 chapters by clinical academics and senior members of the pharmaceutical industry detail the latest breakthroughs in research and development. In asthma, a promising approach is the use of therapy directed against specific Th2 responses through biological antagonists of IL-5, IL-4 and IL-13. There have also been major advances in our understanding of innate immune responses to pathogen-associated molecular patterns, and in the area of Toll-like receptors. Up to date and comprehensive, this book will be of particular relevance to those working in the pharmaceutical industry (in preclinical research and clinical development), to academic researchers in the field of respiratory medicine, and to respiratory health care specialists. Kindle Edition, Ausgabe: 1, Format: Kindle eBook, Label: S. Karger, S. Karger, Produktgruppe: eBooks, Publiziert: 2010-08-31, Freigegeben: 2010-08-31, Studio: S. Karger.
2
New Drugs and Targets for Asthma and COPD (Progress in Respiratory Research) (2010)
EN NW FE EB DLISBN: 9783805595674 bzw. 3805595670, in Englisch, 310 Seiten, S. Karger, neu, Erstausgabe, E-Book, elektronischer Download.
Lieferung aus: Deutschland, E-Book zum Download, Versandkostenfrei.
Asthma, allergy and chronic obstructive lung disease are common throughout the world and are increasing in incidence, particularly in the developing world. This volume provides a state-of-the-art account of the identification of new targets and the development of new therapies for these conditions. Some 40 chapters by clinical academics and senior members of the pharmaceutical industry detail the latest breakthroughs in research and development. In asthma, a promising approach is the use of therapy directed against specific Th2 responses through biological antagonists of IL-5, IL-4 and IL-13. There have also been major advances in our understanding of innate immune responses to pathogen-associated molecular patterns, and in the area of Toll-like receptors. Up to date and comprehensive, this book will be of particular relevance to those working in the pharmaceutical industry (in preclinical research and clinical development), to academic researchers in the field of respiratory medicine, and to respiratory health care specialists. Kindle Edition, Ausgabe: 1, Format: Kindle eBook, Label: S. Karger, S. Karger, Produktgruppe: eBooks, Publiziert: 2010-08-31, Freigegeben: 2010-08-31, Studio: S. Karger.
Asthma, allergy and chronic obstructive lung disease are common throughout the world and are increasing in incidence, particularly in the developing world. This volume provides a state-of-the-art account of the identification of new targets and the development of new therapies for these conditions. Some 40 chapters by clinical academics and senior members of the pharmaceutical industry detail the latest breakthroughs in research and development. In asthma, a promising approach is the use of therapy directed against specific Th2 responses through biological antagonists of IL-5, IL-4 and IL-13. There have also been major advances in our understanding of innate immune responses to pathogen-associated molecular patterns, and in the area of Toll-like receptors. Up to date and comprehensive, this book will be of particular relevance to those working in the pharmaceutical industry (in preclinical research and clinical development), to academic researchers in the field of respiratory medicine, and to respiratory health care specialists. Kindle Edition, Ausgabe: 1, Format: Kindle eBook, Label: S. Karger, S. Karger, Produktgruppe: eBooks, Publiziert: 2010-08-31, Freigegeben: 2010-08-31, Studio: S. Karger.
3
New Drugs and Targets for Asthma and COPD
~EN NW EB DLISBN: 9783805595674 bzw. 3805595670, vermutlich in Englisch, S. Karger, neu, E-Book, elektronischer Download.
Lieferung aus: Deutschland, Versandkostenfrei.
New Drugs and Targets for Asthma and COPD: Asthma, allergy and chronic obstructive lung disease are common throughout the world and are increasing in incidence, particularly in the developing world. This volume provides a state-of-the-art account of the identification of new targets and the development of new therapies for these conditions. Some 40 chapters by clinical academics and senior members of the pharmaceutical industry detail the latest breakthroughs in research and development. In asthma, a promising approach is the use of therapy directed against specific Th2 responses through biological antagonists of IL-5, IL-4 and IL-13. There have also been major advances in our understanding of innate immune responses to pathogen-associated molecular patterns, and in the area of Toll-like receptors. Up to date and comprehensive, this book will be of particular relevance to those working in the pharmaceutical industry (in preclinical research and clinical development), to academic researchers in the field of respiratory medicine, and to respiratory health care specialists. Englisch, Ebook.
New Drugs and Targets for Asthma and COPD: Asthma, allergy and chronic obstructive lung disease are common throughout the world and are increasing in incidence, particularly in the developing world. This volume provides a state-of-the-art account of the identification of new targets and the development of new therapies for these conditions. Some 40 chapters by clinical academics and senior members of the pharmaceutical industry detail the latest breakthroughs in research and development. In asthma, a promising approach is the use of therapy directed against specific Th2 responses through biological antagonists of IL-5, IL-4 and IL-13. There have also been major advances in our understanding of innate immune responses to pathogen-associated molecular patterns, and in the area of Toll-like receptors. Up to date and comprehensive, this book will be of particular relevance to those working in the pharmaceutical industry (in preclinical research and clinical development), to academic researchers in the field of respiratory medicine, and to respiratory health care specialists. Englisch, Ebook.
4
New Drugs and Targets for Asthma and COPD
~EN NW EBISBN: 9783805595674 bzw. 3805595670, vermutlich in Englisch, Karger, S. Inc. neu, E-Book.
Lieferung aus: Vereinigte Staaten von Amerika, Lagernd.
New-Drugs-and-Targets-for-Asthma-and-Copd~~T-T-Hansel, New Drugs and Targets for Asthma and COPD, NOOK Book (eBook).
New-Drugs-and-Targets-for-Asthma-and-Copd~~T-T-Hansel, New Drugs and Targets for Asthma and COPD, NOOK Book (eBook).
7
New Drugs and Targets for Asthma and COPD (Progress in Respiratory Research) (2010)
DE HC NWISBN: 9783805595667 bzw. 3805595662, in Deutsch, S Karger Pub, gebundenes Buch, neu.
Lieferung aus: Vereinigte Staaten von Amerika, Versandkostenfrei.
Von Händler/Antiquariat, Book Deals [60506629], Lewiston, NY, U.S.A.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Von Händler/Antiquariat, Book Deals [60506629], Lewiston, NY, U.S.A.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
8
New Drugs and Targets for Asthma and COPD (Progress in Respiratory Research) (2010)
DE HCISBN: 9783805595667 bzw. 3805595662, in Deutsch, S Karger Pub, gebundenes Buch.
Lieferung aus: Vereinigte Staaten von Amerika, Versandkostenfrei.
Von Händler/Antiquariat, Book Deals [60506629], Lewiston, NY, U.S.A.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Von Händler/Antiquariat, Book Deals [60506629], Lewiston, NY, U.S.A.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Lade…